IMRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 25.00%

Insider Buying (Last 12 Months): $266,645.33

Insider Selling (Last 12 Months): $3,053,818.52

Immuneering Insider Trading History Chart

Immuneering Share Price & Price History

^$1.87

▲ +0.01 (0.54%)

As of 11/1/2024 01:00 AM ET

Days: 30 | 90 | 365

Tim Sykes’ Urgent Trade Alert: “Make this move now”

From Timothy Sykes | Ad

Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.

Click here to see the surprising reason why

Immuneering Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2024	Cormorant Asset Management, Lp	Major Shareholder	Sell	400,000	$2.90	$1,160,000.00	2,895,273
3/22/2024	Harold Eugene Brakewood	Insider	Buy	3,900	$2.57	$10,023.00	3,900
3/22/2024	Peter Feinberg	Director	Buy	25,000	$2.55	$63,750.00	111,766
3/21/2024	Mallory Morales	CAO	Buy	1,107	$2.72	$3,011.04	7,885
3/20/2024	Leah R Neufeld	Insider	Buy	3,818	$2.88	$10,995.84	10,029
3/19/2024	Benjamin J Zeskind	CEO	Buy	20,000	$2.77	$55,400.00	2,281,852
3/18/2024	Ann E Berman	Director	Buy	57,965	$2.13	$123,465.45	67,465
3/14/2024	Cormorant Asset Management, Lp	Major Shareholder	Sell	509,091	$3.72	$1,893,818.52	3,695,273
5/25/2022	Brett Matthew Hall	Insider	Buy	2,551	$3.92	$9,999.92	332,685
5/17/2022	Michael Bookman	General Counsel	Buy	1,000	$4.88	$4,880.00	2,402
5/16/2022	Laurie Keating	Director	Buy	7,000	$5.00	$35,000.00	14,000
5/12/2022	Biren Amin	CFO	Buy	1,000	$4.42	$4,420.00	7,898
3/23/2022	Benjamin J Zeskind	CEO	Buy	3,000	$8.02	$24,060.00
3/22/2022	Scott Barrett	Insider	Buy	900	$7.49	$6,741.00
3/15/2022	Ann E Berman	Director	Buy	6,000	$6.40	$38,400.00

Crypto Crash Ahead? (27 Experts Weigh In)

From Crypto 101 Media | Ad

Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!

Click here to reserve your spot at the emergency crypto summit now.

SEC Filings (Institutional Ownership Changes) for Immuneering (NASDAQ:IMRX)

67.65% of Immuneering stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Immuneering Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/16/2024	Vontobel Holding Ltd.	10,000	$25K	0.0%	N/A	0.034%
10/10/2024	Exchange Traded Concepts LLC	58,349	$0.15M	0.0%	-22.1%	0.197%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	34,609	$44K	0.0%	N/A	0.117%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	34,609	$44K	0.0%	N/A	0.117%
8/14/2024	Marshall Wace LLP	384,075	$0.49M	0.0%	N/A	1.295%
8/12/2024	XTX Topco Ltd	34,159	$44K	0.0%	+37.3%	0.115%
8/9/2024	Renaissance Technologies LLC	349,100	$0.45M	0.0%	N/A	1.177%
8/6/2024	Acadian Asset Management LLC	53,445	$67K	0.0%	N/A	0.180%
5/15/2024	Price T Rowe Associates Inc. MD	910,266	$2.63M	0.0%	-73.1%	3.070%
5/10/2024	Vanguard Group Inc.	1,203,666	$3.48M	0.0%	+12.1%	4.060%
2/12/2024	TD Asset Management Inc	197,876	$1.45M	0.0%	-30.4%	0.676%
1/5/2024	Exchange Traded Concepts LLC	17,416	$0.13M	0.0%	+34.0%	0.060%
11/15/2023	Adage Capital Partners GP L.L.C.	195,000	$1.50M	0.0%	+11.4%	0.666%
11/14/2023	Corton Capital Inc.	18,847	$0.15M	0.1%	N/A	0.064%
11/13/2023	Southport Management L.L.C.	17,500	$0.13M	0.7%	N/A	0.060%
11/13/2023	FMR LLC	612,168	$4.70M	0.0%	-7.0%	2.092%
11/13/2023	PNC Financial Services Group Inc.	20,000	$0.15M	0.0%	N/A	0.068%
10/27/2023	TD Asset Management Inc	284,476	$2.19M	0.0%	+100.0%	0.972%
10/18/2023	Exchange Traded Concepts LLC	12,999	$100K	0.0%	-12.7%	0.044%
9/8/2023	Tucker Asset Management LLC	11,036	$0.11M	0.0%	N/A	0.038%
8/15/2023	HighVista Strategies LLC	253,110	$2.57M	1.2%	N/A	0.865%
8/14/2023	Cormorant Asset Management LP	4,204,364	$42.63M	2.4%	+76.2%	14.369%
8/11/2023	ExodusPoint Capital Management LP	127,719	$1.30M	0.0%	+48.0%	0.436%
8/9/2023	TD Asset Management Inc	142,238	$1.44M	0.0%	-1.3%	0.486%
8/4/2023	American International Group Inc.	9,761	$99K	0.0%	N/A	0.033%
8/2/2023	Bank of Montreal Can	714,037	$8M	0.0%	N/A	2.441%
7/26/2023	Janney Montgomery Scott LLC	22,135	$0.22M	0.0%	N/A	0.076%
7/20/2023	Exchange Traded Concepts LLC	14,884	$0.15M	0.0%	N/A	0.051%
5/11/2023	ExodusPoint Capital Management LP	86,297	$0.84M	0.0%	N/A	0.295%
5/9/2023	Y Intercept Hong Kong Ltd	11,114	$0.11M	0.0%	N/A	0.038%
11/15/2022	Citadel Advisors LLC	2,184,909	$31.29M	0.0%	-0.7%	8.273%
8/4/2022	TD Asset Management Inc.	147,661	$0.80M	0.0%	+21.8%	0.560%
5/10/2022	TD Asset Management Inc.	121,201	$0.78M	0.0%	+253.4%	0.459%
2/15/2022	Adage Capital Partners GP L.L.C.	314,000	$5.08M	0.0%	N/A	1.210%
2/14/2022	Citadel Advisors LLC	2,058,102	$32.04M	0.0%	+0.1%	7.934%
2/8/2022	Northern Trust Corp	75,891	$1.23M	0.0%	+4.5%	0.293%
2/2/2022	New York State Common Retirement Fund	4,637	$75K	0.0%	+172.8%	0.018%
1/28/2022	Allspring Global Investments Holdings LLC	9,228	$0.15M	0.0%	N/A	0.036%
12/3/2021	Perceptive Advisors LLC	681,051	$18.08M	0.3%	N/A	2.625%
11/16/2021	Suvretta Capital Management LLC	200,000	$5.31M	0.1%	N/A	0.771%
11/16/2021	Metropolitan Life Insurance Co NY	2,814	$75K	0.0%	N/A	0.011%
11/16/2021	Millennium Management LLC	89,788	$2.38M	0.0%	N/A	0.346%
11/16/2021	Citadel Advisors LLC	2,055,459	$52.40M	0.0%	N/A	7.924%
11/15/2021	Rock Springs Capital Management LP	1,089,816	$28.94M	0.6%	N/A	4.201%
11/15/2021	Marshall Wace LLP	13,149	$0.35M	0.0%	N/A	0.051%
11/15/2021	Caas Capital Management LP	40,000	$1.06M	0.0%	N/A	0.154%
11/12/2021	Ghisallo Capital Management LLC	15,000	$0.40M	0.0%	N/A	0.058%
11/12/2021	Geode Capital Management LLC	122,319	$3.25M	0.0%	N/A	0.472%
11/10/2021	Citigroup Inc.	1,246	$33K	0.0%	N/A	0.005%
11/9/2021	BlackRock Inc.	1,524,374	$40.47M	0.0%	N/A	5.877%
11/9/2021	TD Asset Management Inc.	34,296	$0.91M	0.0%	N/A	0.132%
11/4/2021	Deutsche Bank AG	4,752	$0.13M	0.0%	N/A	0.018%
11/2/2021	New York State Common Retirement Fund	1,700	$45K	0.0%	N/A	0.007%

Data available starting January 2016

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.

Today's Range

Now: $1.87

$1.84

$1.95

50 Day Range

MA: $2.02

$1.11

$3.21

52 Week Range

Now: $1.87

$1.00

$8.89

Volume

151,632 shs

Average Volume

2,349,345 shs

Market Capitalization

$55.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Immuneering?: Immuneering's top insider shareholders include:
Cormorant Asset Management, Lp (Major Shareholder)
Benjamin J Zeskind (CEO)
Peter Feinberg (Director)
Ann E Berman (Director)
Leah R Neufeld (Insider)
Mallory Morales (CAO)
Harold Eugene Brakewood (Insider)
Learn More about top insider investors at Immuneering.
Who are the major institutional investors of Immuneering?: Immuneering's top institutional shareholders include:
Exchange Traded Concepts LLC — 0.20%
Vontobel Holding Ltd. — 0.03%
Learn More about top institutional investors of Immuneering stock.
Which institutional investors are selling Immuneering stock?: Within the last quarter, IMRX stock was sold by these institutional investors:
Exchange Traded Concepts LLC
Which institutional investors are buying Immuneering stock?: Within the last quarter, IMRX stock was bought by institutional investors including:
Vontobel Holding Ltd.
Within the previous year, these company insiders have bought Immuneering stock:
Cormorant Asset Management, Lp (Major Shareholder)
Benjamin J Zeskind (CEO)
Peter Feinberg (Director)
Ann E Berman (Director)
Leah R Neufeld (Insider)
Mallory Morales (CAO)
Learn More investors buying Immuneering stock.